Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2020

Open Access 01-12-2020 | Graft-Versus-Host Disease | Research article

Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project

Authors: Janette Ribaut, Lynn Leppla, Alexandra Teynor, Sabine Valenta, Fabienne Dobbels, Leah L. Zullig, Sabina De Geest, the SMILe study team

Published in: BMC Health Services Research | Issue 1/2020

Login to get access

Abstract

Background

Medication adherence to immunosuppressants in allogeneic stem cell transplantation (alloSCT) is essential to achieve favorable clinical outcomes (e.g. control of Graft-versus-Host Disease). Over 600 apps supporting medication adherence exist, yet they lack successful implementation and sustainable use likely because of lack of end-user involvement and theoretical underpinnings in their development and insufficient attention to implementation methods to support their use in real-life settings. Medication adherence has three phases: initiation, implementation and persistence. We report the theory-driven development of an intervention module to support medication adherence (implementation and persistence phase) in alloSCT outpatients as a first step for future digitization and implementation in clinical setting within the SMILe project (Development, implementation and testing of an integrated care model in allogeneic SteM cell transplantatIon faciLitated by eHealth).

Methods

We applied Michie’s Behavior Change Wheel (BCW) and the Capability-Opportunity-Motivation and Behavior (COM-B) model using three suggested stages followed by one stage added by our team regarding preparation for digitization of the intervention: (I) Defining the problem in behavioral terms; (II) Identifying intervention options; (III) Identifying content and implementation options; (IV) SMILe Care Model Prototype Development. Scientific evidence, data from a contextual analysis and patients’/caregivers’ and clinical experts’ inputs were compiled to work through these steps.

Results

(I) Correct immunosuppressant taking and timing were defined as target behaviors. The intervention’s focus was determined within the COM-B dimensions Capability (lack of knowledge, lack of routine), Opportunity (lack of cues, interruptions in daily routine) and Motivation (lack of problem solving, trivialization). (II) Five intervention functions were chosen, i.e. education, training, modelling, persuasion and enablement. (III) Twenty-four behavior change techniques were selected, e.g., goal setting, action planning and problem solving. (IV) Finally, seventeen user stories were developed to guide the SMILeApp’s software development process.

Conclusion

Our example on the theory-driven development of an intervention module in alloSCT delivered by eHealth and transplant team using a rigorous 3 + 1-stage approach based on BCW, COM-B and agile software development techniques, can be used as methodological guidance for other eHealth intervention developers. Our approach has the potential to enhance successful implementation and sustained use of eHealth solutions in real-life settings.
Appendix
Available only for authorised users
Footnotes
1
Although implementation adherence uses the same word, this does not equate with implementation in the context of implementation science.
 
Literature
1.
Maedler-Kron C, Marcus VA, Michel RP. Hematopoietic Stem Cell Transplantation. In: Michel RP, Berry GJ, editors. Pathology of Transplantation: A Practical Diagnostic Approach. Cham: Springer International Publishing; 2016. p. 401–49.
2.
Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23(4):538–51.PubMed
3.
Gee PM, Greenwood DA, Paterniti DA, Ward D, Miller LMS. The eHealth enhanced chronic care model: a theory derivation approach. J Med Internet Res. 2015;17(4):e86.PubMedPubMedCentral
4.
De Geest S, Zullig LL, Dunbar-Jacob J, Helmy R, Hughes DA, Wilson IB, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169:30–5.PubMedPubMedCentral
5.
Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73(5):691–705.PubMedPubMedCentral
6.
Smith A, Wisloff F, Samson D. Guidelines on the diagnosis and management of multiple myeloma 2005. Br J Haematol. 2006;132(4):410–51.PubMed
7.
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant. 2009;44(8):453.PubMed
8.
Tabbara IA, Zimmerman K, Morgan C, Nahleh Z. Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med. 2002;162(14):1558–66.PubMed
9.
Hilgendorf I, Greinix H, Halter JP, Lawitschka A, Bertz H, Wolff D. Long-term follow-up after allogeneic stem cell transplantation. Dtsch Arztebl Int. 2015;112(4):51.PubMedPubMedCentral
10.
Wingard JR, Majhail NS, Brazauskas R, Wang Z, Sobocinski KA, Jacobsohn D, et al. Long-term survival and late deaths after allogeneic hem-atopoietic cell transplantation. J Clin Oncol. 2011;29:2230–9.PubMedPubMedCentral
11.
Wood WA, Chai X, Weisdorf D, Martin PJ, Cutler C, Inamoto Y, et al. Comorbidity burden in patients with chronic GVHD. Bone Marrow Transplant. 2013;48:1429–36.PubMedPubMedCentral
12.
Gresch B, Kirsch M, Fierz K, Halter JP, Nair G, Denhaerynck K, et al. Medication nonadherence to immunosuppressants after adult allogeneic haematopoietic stem cell transplantation: a multicentre cross-sectional study. Bone Marrow Transplant. 2017;52(2):304.PubMed
13.
Kirsch M, Götz A, Halter JP, Schanz U, Stussi G, Dobbels F, et al. Differences in health behaviour between recipients of allogeneic haematopoietic SCT and the general population: a matched control study. Bone Marrow Transplant. 2014;49(9):1223.PubMed
14.
Flodgren G, Rachas A, Farmer AJ, Inzitari M, Shepperd S. Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2015;9:CD002098.
15.
Dobbels F, De Bleser L, Berben L, Kristanto P, Dupont L, Nevens F, et al. Efficacy of a medication adherence enhancing intervention in transplantation: the MAESTRO-Tx trial. J Heart Lung Transplant. 2017;36(5):499–508.PubMed
16.
Schmid A, Hils S, Kramer-Zucker A, Bogatyreva L, Hauschke D, De Geest S, et al. Telemedically supported case Management of Living-Donor Renal Transplant Recipients to optimize routine evidence-based aftercare: a single-center randomized controlled trial. Am J Transplant. 2017;17(6):1594–605.PubMed
17.
Linn AJ, Vervloet M, van Dijk L, Smit EG, Van Weert JC. Effects of eHealth interventions on medication adherence: a systematic review of the literature. J Med Internet Res. 2011;13(4):e103.PubMedPubMedCentral
18.
De Bleser L, Matteson M, Dobbels F, Russell C, De Geest S. Interventions to improve medication-adherence after transplantation: a systematic review. Transpl Int. 2009;22(8):780–97.PubMed
19.
Low JK, Williams A, Manias E, Crawford K. Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review. Nephrol Dial Transplant. 2014;30(5):752–61.PubMed
20.
Welch MA, Kaled ES. Ensuring optimal adherence to BCR-ABL1 tyrosine kinase inhibitor therapy for chronic myeloid leukemia. Commun Oncol. 2013;10(5):138–46.
21.
Zullig LL, Deschodt M, Liska J, Bosworth H, De Geest S. Moving from the trial to the real world: improving medication adherence using insights of implementation science. Annu Rev Pharmacol Toxicol. 2019;59:423–45.PubMed
22.
Ahmed I, Ahmad NS, Ali S, Ali S, George A, Danish HS, et al. Medication adherence apps: review and content analysis. JMIR mHealth and uHealth. 2018;6:e62.PubMedPubMedCentral
23.
Morrissey EC, Corbett TK, Walsh JC, Molloy GJ. Behavior change techniques in apps for medication adherence: a content analysis. Am J Prev Med. 2016;50(5):e143–6.PubMed
24.
Aitken M, Clancy B, Nass D. The growing value of digital health. IQVIA Institute for Human Data Science. 2017:1–76.
25.
Webb T, Joseph J, Yardley L, Michie S. Using the internet to promote health behavior change: a systematic review and meta-analysis of the impact of theoretical basis, use of behavior change techniques, and mode of delivery on efficacy. J Med Internet Res. 2010;12:e4.PubMedPubMedCentral
26.
Prendergast MB, Gaston RS. Optimizing medication adherence: an ongoing opportunity to improve outcomes after kidney transplantation. Clin J Am Soc Nephrol. 2010;5(7):1305–11.PubMedPubMedCentral
27.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4(1):50.PubMedPubMedCentral
28.
Horne R, Weinman J, Barber N, Elliott R, Morgan M, Cribb A, et al. Concordance, adherence and compliance in medicine taking. London: NCCSDO; 2005:40–6.
29.
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62.PubMedPubMedCentral
30.
McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. Jama. 2002;288(22):2868–79.PubMed
31.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):CD000011.PubMedCentral
32.
Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm. 2003;60(7):657–65.PubMed
33.
West R. Theory of addiction. Oxford: Blackwells; 2006.
34.
Michie S, Van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6(1):42.PubMedPubMedCentral
35.
Abrahamsson P, Salo O, Ronkainen J, Warsta J. Agile software development methods: Review and analysis. Espoo: VTT publication 478; 2017.
36.
Leppla L, Mielke J, Kunze M, Mauthner O, Teynor A, Valenta S, et al. Clinicians and patients perspectives on follow-up care and eHealth support after allogeneic hematopoietic stem cell transplantation: a mixed-methods contextual analysis as part of the SMILe study. Eur J Oncol Nurs. 2020;45:101723.PubMed
37.
Murphy M, McCloughen A, Curtis K. Using theories of behaviour change to transition multidisciplinary trauma team training from the training environment to clinical practice. Implement Sci. 2019;14:43.PubMedPubMedCentral
38.
Jackson C, Eliasson L, Barber N, Weinman J. Applying COM-B to medication adherence: a suggested framework for research and interventions. European Health Psychologist. 2014;16(1):7–17.
39.
Bixby DL. Managing inadequate responses to frontline treatment of chronic myeloid leukemia: a case-based review. Cancer Treat Rev. 2012;39(3):241–51.PubMed
40.
Talati C, Ontiveros EP, Griffiths EA, Wang ES, Wetzler M. How we will treat chronic myeloid leukemia in 2016. Blood Rev. 2015;29(2):137–42.PubMed
41.
Lehrer J, Brissot E, Ruggeri A, Dulery R, Vekhoff A, Battipaglia G, et al. Medication adherence among allogeneic hematopoietic stem cell transplant recipients: a pilot single-center study. Bone Marrow Transplant. 2018;53(2):231–3.PubMed
42.
Bertz H, Finke J. Transplant manual: Hämatopoetische Zelltransplantation (HZT). Freiburg: University Hospital of Freiburg; 2016.
43.
Hoodin F. Psychological and behavioral correlates of medical adherence among adult bone marrow transplant recipients. Detroit: Wayne State University; 1995.
44.
Montesinos P, Rodríguez-Veiga R, Boluda B, Martínez-Cuadrón D, Cano I, Lancharro A, et al. Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis. Bone Marrow Transplant. 2015;50:1465–72.PubMed
45.
Schäfer-Keller P, Steiger J, Bock A, Denhaerynck K, De Geest S. Diagnostic accuracy of measurement methods to assess nonadherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616–26.PubMed
46.
De Geest S, Abraham I, Moons P, Vandeputte M, Van Cleemput J, Evers G, et al. Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. J Heart Lung Transplant. 1998;17:854–63.PubMed
47.
Pinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9:2597–606.PubMed
48.
Muduma G, Shupo FC, Dam S, Hawken NA, Aballea S, Odeyemi I, et al. Patient survey to identify reasons for non-adherence and elicitation of quality of life concepts associated with immunosuppressant therapy in kidney transplant recipients. Patient Prefer Adherence. 2016;10:27.PubMedPubMedCentral
49.
Tong A, Howell M, Wong G, Webster AC, Howard K, Craig JC. The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrol Dial Transplant. 2010;26(1):344–54.PubMed
50.
Williams A, Low JK, Manias E, Crawford K. The transplant team’s support of kidney transplant recipients to take their prescribed medications: a collective responsibility. J Clin Nurs. 2016;25(15–16):2251–61.PubMed
51.
Rebafka A. Medication adherence after renal transplantation—a review of the literature. J Ren Care. 2016;42(4):239–56.PubMed
52.
Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, et al. Motivations, challenges, and attitudes to self-management in kidney transplant recipients: a systematic review of qualitative studies. Am J Kidney Dis. 2016;67(3):461–78.PubMed
53.
O'Grady JG, Asderakis A, Bradley R, Burnapp L, McPake DM, Perrin M, et al. Multidisciplinary insights into optimizing adherence after solid organ transplantation. Transplantation. 2010;89(5):627–32.PubMed
54.
Tong A, Morton RL, Webster AC. How qualitative research informs clinical and policy decision making in transplantation: a review. Transplantation. 2016;100(9):1997–2005.PubMed
55.
Pinter J, Hanson CS, Craig JC, Chapman JR, Budde K, Halleck F, et al. ‘I feel stronger and younger all the time’—perspectives of elderly kidney transplant recipients: thematic synthesis of qualitative research. Nephrol Dial Transplant. 2016;31(9):1531–40.PubMed
56.
Low JK, Crawford K, Manias E, Williams A. Stressors and coping resources of Australian kidney transplant recipients related to medication taking: a qualitative study. J Clin Nurs. 2017;26(11–12):1495–507.PubMed
57.
Israni A, Dean C, Kasel B, Berndt L, Wildebush W, Wang CJ. Why do patients forget to take immunosuppression medications and miss appointments: can a mobile phone app help? JMIR Public Health Surveill. 2016;2(1):e15.PubMedPubMedCentral
58.
Low JK, Crawford K, Manias E, Williams A. A compilation of consumers’ stories: the development of a video to enhance medication adherence in newly transplanted kidney recipients. J Adv Nurs. 2016;72(4):813–24.PubMed
59.
Janelle C, O’Connor K, Dupuis G. Evaluating illness representations in heart transplant patients. J Health Psychol. 2016;21(9):1850–9.PubMed
60.
Williams A, Crawford K, Manias E, Ellis C, Mullins K, Howe K, et al. Examining the preparation and ongoing support of adults to take their medications as prescribed in kidney transplantation. J Eval Clin Pract. 2015;21(2):180–6.PubMed
61.
Ivarsson B, Ekmehag B, Sjöberg T. Patients’ experiences of information and support during the first six months after heart or lung transplantation. Eur J Cardiovasc Nurs. 2013;12(4):400–6.PubMed
62.
Denhaerynck K, Berben L, Dobbels F, Russell CL, Crespo-Leiro MG, Poncelet AJ, et al. Multilevel factors are associated with immunosuppressant nonadherence in heart transplant recipients: the international BRIGHT study. Am J Transplant. 2018;18(6):1447–60.PubMedPubMedCentral
63.
Boaz A, Morgan M. Working to establish ‘normality’post-transplant: a qualitative study of kidney transplant patients. Chronic illn. 2014;10(4):247–58.PubMed
64.
De Geest S, Burkhalter H, Bogert L, Berben L, Glass TR, Denhaerynck K, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant nonadherence to immunosuppressives: the Swiss transplant cohort study. Transpl Int. 2014;27:657–66.PubMed
65.
Cooke L, Chung C, Grant M. Psychosocial Care for Adolescent and Young Adult Hematopoietic Cell Transplant Patients. J Psychosoc Oncol. 2011;29(4):394–414.PubMedPubMedCentral
66.
Michie S, Atkins L, West R. The behaviour change wheel : a guide to designing interventions. Great Britain: Silverback Publishing; 2014.
67.
Brito Félix I, Pereira Guerreiro M, Cavaco A, Paula Cláudio A, Mendes A, Balsa J, et al. Development of a complex intervention to improve adherence to antidiabetic medication in older people using an anthropomorphic virtual assistant software. Front Pharmacol. 2019;10:680.
68.
Lucas B, Brammen D, Schirrmeister W, Aleyt J, Kulla M, Roehrig R, et al. Requirements for a sustainable standardization and digitalization in clinical emergency and acute medicine. Unfallchirurg. 2019;122:243–6.PubMed
69.
Conn VS, Enriquez M, Ruppar TM, Chan KC. Meta-analyses of theory use in medication adherence intervention research. Am J Health Behav. 2016;40:155–71.PubMedPubMedCentral
70.
Lyon AR, Bruns EJ. User-centered redesign of evidence-based psycho-social interventions to enhance implementation—hospitable soil or better seeds? JAMA Psychiatry. 2019;76(1):–4.
71.
Yzer M. The integrative model of behavioral prediction as a tool for designing health messages. In: Hyuniyi C, editor. Health communication message design: Theory and practice; 2012. p. 21–40.
72.
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of beh. Ann Behav Med. 2013;46:81–95.PubMed
73.
Möhler R, Köpke S, Meyer G. Criteria for reporting the development and evaluation of complex interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16(1):204.PubMedPubMedCentral
74.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. Bmj. 2014;348:g1687.PubMed
Metadata
Title
Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project
Authors
Janette Ribaut
Lynn Leppla
Alexandra Teynor
Sabine Valenta
Fabienne Dobbels
Leah L. Zullig
Sabina De Geest
the SMILe study team
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2020
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-020-05636-1

Other articles of this Issue 1/2020

BMC Health Services Research 1/2020 Go to the issue

Research article

The policy implementation gap of school oral health programmes in Tshwane, South Africa: a qualitative case study

Research article

The psychometric properties of the respectful maternity care (RMC) for an Iranian population

Research article

Paediatric nurses’ general self-efficacy, perceived organizational support and perceived professional benefits from Class A tertiary hospitals in Jilin province of China: the mediating effect of nursing practice environment

Research article

Evaluating a young-onset dementia service from two sides of the coin: staff and service user perspectives

Research article

Improving clinical outcomes and patient satisfaction among patients with coronary artery disease: an example of enhancing regional integration between a cardiac centre and a referring hospital

Research article

Communication skills training for physicians improves health literacy and medical outcomes among patients with hypertension: a randomized controlled trial